Martine van Grotel

The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia

Pieter Van Vlierberghe, Martine van Grotel, Joëlle Tchinda et al. · Blood · 2008 · 222 citations · Full text

The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia

Pieter Van Vlierberghe, Martine van Grotel, H. Berna Beverloo et al. · Blood · 2006 · 165 citations · Full text

Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences

Martine van Grotel, Jules P.P. Meijerink, Elisabeth R. van Wering et al. · Leukemia · 2007 · 142 citations · Full text

Pediatric T-all, Autoimmune Disease, Genetic Disorder +13

The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.

Martine van Grotel, Jules P.P. Meijerink, H. Berna Beverloo et al. · PubMed · 2006 · 106 citations

Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study

Eva Clemens, Andrica de Vries, Saskia F.M. Pluijm et al. · European Journal of Cancer · 2016 · 95 citations

Medicine, Dcog Late-effects Study, Cancer Prevention +7